Lab21: filling a niche in centralised high-tech diagnostic services
This article was originally published in Clinica
Executive Summary
While centralised high-tech molecular diagnostics testing centres are common in the US and Asia, Europe has so far failed to catch on to the trend. UK diagnostics group Lab21 recognises this and hopes to address this shortfall. CEO Jerry Walker and CSO Berwyn Clarke spoke to Claire Thomas about their plans for expansion